Sameer Khandhar is a Cardiology physician affiliated with University of Pennsylvania. OpenAlex indexes 71 publications with 2,450 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
51 N 39th St
Phi 2c
Philadelphia, PA 19104
Telephone
215-662-9010Registry record last updated 18 Jul 2018.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Edwards Lifesciences CorporationProgram year20251 payment
- W. L. Gore & Associates, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.4%Statin25.3%Rosuvastatin Calcium50%Atorvastatin Calcium50%Part D≥86 patientsBeta blocker13.3%Metoprolol Succinate48%Carvedilol42%Metoprolol Tartrate10%Part D≥43 patients+ 15 more classes in this area
Blood & clotting
10.8%Factor Xa inhibitor6%Eliquis88%Xarelto12%Part D<11 patientsP2Y12 inhibitor3.8%Clopidogrel100%Part D≥35 patients+ 1 more class in this area
Metabolism & gastrointestinal
0.8%SGLT2 inhibitor0.8%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of Catheter-Directed Thrombolysis Device Type and Dosing on Treatment Outcomes in Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis
Journal of Vascular and Interventional Radiology
2025 - Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
Journal of the American College of Cardiology
2024 - Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia
Annals of Internal Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Raquel Gur, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”